Shop Research Compounds

Gastric-derived pentadecapeptide studied for tissue repair and angiogenesis.

Triple GLP-1/GIP/glucagon receptor agonist studied for metabolic signaling.

Thymosin Beta-4 fragment studied for cell migration and repair.

Copper tripeptide studied for tissue remodeling and matrix signaling.

BPC-157 and TB-500 tissue-repair research blend.

GHRH plus ghrelin-agonist blend for dual GH-axis study.

Stabilized GHRH analog studied for GH-axis and metabolic endpoints.

Selective ghrelin-receptor pentapeptide GH secretagogue.

Mitochondrial-derived peptide studied for AMPK and metabolic signaling.

GHK-Cu, BPC-157 and TB-500 dermal-research blend.

Four-part repair blend: BPC-157, TB-500, GHK-Cu, KPV.

Essential coenzyme studied for cellular energy and sirtuin signaling.

ACTH(4-10) analog studied for nootropic and neurotrophic signaling.

Tuftsin-analog heptapeptide studied for anxiolytic and neuroimmune signaling.

Alpha-MSH tripeptide fragment studied for anti-inflammatory signaling.

Cardiolipin-binding tetrapeptide studied for mitochondrial bioenergetics.

AEDG tetrapeptide bioregulator studied for telomerase and aging endpoints.

Thymic 28-aa peptide studied for immunomodulatory signaling.

ACTH-derived research neuropeptide explored for cognition and neuroplasticity.

AMPK-activating AMP analog studied as a metabolic exercise mimetic.

EPO-derived peptide studied for tissue protection without erythropoiesis.

Neurotrophic peptide preparation studied for neuroprotective CNS signaling.

D-retro-inverso peptide studied for FOXO4-p53 disruption in senescence.

Endogenous antioxidant tripeptide studied for cellular redox balance.

Glycoprotein hormone studied for gonadotropin-receptor signaling.

Mitochondrial-derived peptide studied for cytoprotective signaling.

Long-acting IGF-1 analog studied for growth and IGF-1R signaling.

MC1R-agonist alpha-MSH analog studied for melanogenesis.

Non-selective melanocortin agonist studied for pigmentation pathways.

Spadin-derived TREK-1 blocker studied for neuroplasticity research.

Melanocortin (MC4R) agonist studied for CNS-mediated signaling.

NNMT inhibitor studied for NAD+ salvage and adipocyte metabolism.

Modified GH fragment (176-191) studied for lipolytic signaling.

Long-acting albumin-bound GHRH analog for sustained GH-axis study.

Short-acting GHRH(1-29) analog studied for pulsatile GH release.

Delta sleep-inducing nonapeptide studied for sleep and stress signaling.

Full-length 191-aa recombinant GH studied for somatotropic signaling.

KISS1R decapeptide studied as an upstream HPG-axis regulator.

Nonapeptide OXTR agonist studied for social and neuroendocrine signaling.

EDR peptide bioregulator studied for neuroprotective CNS signaling.

Membrane-active HDM-2-binding peptide studied in p53-pathway research.

GHRH(1-29) analog studied for pituitary GH-release signaling.

Vasoactive intestinal peptide studied for neuroimmune signaling.